Aging, aluminium and basal forebrain lesions modify substrate kinetics of erythrocyte membrane Na,K-ATPase in the rat

Journal of Alzheimer's Disease

Volumn 14, Issue 1, 2008, Pages 85-93

  Jovičić, Milena Erić ^a   Popović, Miroljub ^b   Nešić, Katica Jovanova ^a   Popović, Natalija ^c   Pavlović, Svetlana Jovičić ^d   Rakić, Ljubisav ^e  

^a Institute of Virology Vaccines and Sera Torlak   (Serbia)

^b UNIVERSITY OF MURCIA   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

^d UNIVERSITY OF BELGRADE   (Serbia)

^e SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Aging; Aluminium; Alzheimer's disease; K ATPase; Na; Nucleus basalis magnocellularis; Rats

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM); ALUMINUM; ALUMINUM CHLORIDE; KAINIC ACID; SODIUM;

AGED; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; ENZYME ACTIVITY; ERYTHROCYTE MEMBRANE; FOREBRAIN; MALE; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT; SODIUM CELL LEVEL;

EID: 47849119470     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2008-14108     Document Type: Article

References (69)

1. S. Aggarwal, M. Subberwal, S. Kumar and M. Sharma, Brain tumor and role of beta-carotene, a-tocopherol, superoxide dismutase and glutathione peroxidase, J Cancer Res Ther 2 (2006), 24-27.
2. M. Amano, K. Imataka, K. Suzuki, H. Nakaoka and J. Fujii, Age-related reduction in the number of rabbit erythrocyte Na,K-ATPase, Tohoku J Exp Med 159 (1989), 131-137.
3. W.R. Anderson, J.E. Franck, W.L. Stahl and A.A. Maki, Na,K-ATPase is decreased in hippocampus of kainate-lesioned rats, Epilepsy Res 17 (1994), 221-231.
4. G.W. Arendash, W.J. Millard, A.J. Dunn and E.M. Meyer, Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat, Science 238 (1987), 952-956.
5. K. Bala, B.C. Tripathy and D. Sharma, Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions, Biogerontology 7 (2006), 81-89.
6. R.J. Beninger, K. Jhamandas, R.J. Boegman and S.R. el-Defrawy, Effects of scopolamine and unilateral lesions of the basal forebrain on T-maze spatial discrimination and alternation in rats, Pharmacol Biochem Behav 24 (1986), 1353-1360.
7. H.G. Bernstein, H. Schwarzberg, G. Poeggel and M. Reiser, Intracerebroventricular but not intraperitoneal administration of aluminum attenuates vasopressin-enhanced retrieval of a passive avoidance task in rats, Pharmacol Biochem Behav 47 (1994), 587-590.
8. +-ATPase: Tissue slices versus primary cultures, Brain Res Bull 46 (1998), 423-427.
9. C. Bozzo, M. Goria, C. Marengo, S. Marena, F. Veglia and G. Pagano, Lymphocyte Na,K-ATPase is reduced in aged people, Metabolism 39 (1990), 808-814.
10. D.A. Butterfield, J.Q. Oeswein, M.E. Prunty, K.C. Hisle and W.R. Markesbery, Increased sodium plus potassium adenosine triphosphatase activity in erythrocyte membranes in Huntington's disease, Ann Neurol 4 (1978), 60-62.
11. D.A. Butterfield, T. Reed, S.F. Newman and R. Sultan, Roles of amyloid beta-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment, Free Radic Biol Med 43 (2007), 658-677.
12. M.L. Caspers, T.M. Kwaiser, M.J. Dow, M.J. Fu and P. Grammas, Control of the Na+,K(+)-ATPase under normal and pathological conditions, Mol Chem Neuropathol 19 (1993), 65-81.
13. C.A. Dickey, M.N. Gordon, D.M. Wilcock, D.L. Herber, M.J. Freeman and D. Morgan, Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice, BMC Neurosci 6 (2005), 7.
14. J.T. Dodge, C. Mitchell and D.J. Hanahan, The preparation and chemical characteristic of hemoglobin-free ghost on human erythrocytes, Arch Biochem Biophys 100 (1963), 119-130.
15. R. Dosunmu, J. Wu, M.R. Basha and N.H. Zawia, Environmental and dietary risk factors in Alzheimer's disease, Expert Rev Neurother 7 (2007), 887-900.
16. F. Drago, F. Mauceri, L. Nardo, C. Valerio, N. Lauria, L. Rampello and G. Guidi, Behavioral effects of L-alpha-glycerylphosphorylcholine: influence on cognitive mechanisms in the rat, Pharmacol Biochem Behav 41 (1992), 445-448.
17. W. Dröge and H.M. Schipper, Oxidative stress and aberrant signaling in aging and cognitive decline, Aging Cell 6 (2007), 361-370.
18. S.R. el-Defrawy, F. Coloma, K. Jhamandas, R.J. Boegman, R.J. Beninger and B.A. Wirsching, Functional and neurochemical cortical cholinergic impairment following neurotoxic lesions of the nucleus basalis magnocellularis in the rat, Neurobiol Aging 6 (1985), 325-330.
19. + ATPase) activity in healthy men, J Gerontol 38 (1983), 23-25.
20. G.E. Gibson and H.M. Huang, Oxidative processes in the brain and non-neuronal tissues as biomarkers of Alzheimer's disease, Front Biosci 7 (2002), d1007-d1015.
21. A. Gorini, U. Canosi, E. Devecchi, D. Geroldi and R.F. Villa, ATPase enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex, Prog Neuropsychopharmacol Biol Psychiatry 26 (2002), 81-90.
22. +-ATPase activities in Alzheimer's disease brains, Neurosci Lett 254 (1998), 141-144.
23. D. Hegner, D. Platt, H. Heckers, U. Schloeder and V. Breuninger, Age-dependent physiochemical and biochemical studies of human red cell membranes, Mech Ageing Dev 10 (1979), 117-130.
24. D.J. Hepler, G.L. Wenk, B.L. Cribbs, D.S. Olton and J.T. Coyle, Memory impairments following basal forebrain lesions, Brain Res 346 (1985), 8-14.
25. M. Hokin-Neaverson, D.A. Spiegel, W.A. Burckhardt and J.W. Jefferson, Age and sex differences of erythrocyte sodium pump activity in normal human subjects, Clin Chim Acta 76 (1977), 399-401.
26. R. Jayakumar, J.W. Kusiak, F.J. Chrest, A.A. Demehin, J. Murali, R.P. Wersto, E. Nagababu, L. Ravi and J.M. Rifkind, Red cell perturbations by amyloid beta-protein, Biochim Biophys Acta 1622 (2003), 20-28.
27. B.D. Jordan, Genetic influences on outcome following traumatic brain injury, Neurochem Res 32 (2007), 905-915.
28. K. Jovanova-Nešić, M. Erić-Jovičić and N.H. Spector, Magnetic stimulation of the brain increase Na+, K+-ATPase activity decreased by injection of AlCl3 into nucleus basalis magnocellularis of rats, Int J Neurosci 116 (2006), 681-695.
29. + in Alzheimer's disease: difference from the age-matched control but similarity to the rat model, FEBS Lett 531 (2002), 241-244.
30. K.G. Karageuzyan, Oxidative stress in the molecular mechanism of pathogenesis at different diseased states of organism in clinics and experiment, Curr Drug Targets Inflamm Allergy 4 (2005), 85-98.
31. J. Kaur, D. Sharma and R. Singh, Regional effects of ageing on Na+,K(+)-ATPase activity in rat brain and correlation with multiple unit action potentials and lipid peroxidation, Indian J Biochem Biophys 35 (1998), 364-371.
32. E.M. Kawamoto, C.D. Munhoz, I. Glezer, V.S. Bahia, P. Caramelli, R. Nitrini, R. Gorjão, R. Curi, C. Scavone and T. Marcourakis, Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease, Neurobiol Aging 26 (2005), 857-864.
33. S. Kumar, Aluminium-induced biphasic effect, Med Hypotheses 52 (1999), 557-559.
34. G.J. Lees, Inhibition of sodium-potassium-ATPase: a potentially ubiquitous mechanism contributing to central nervous system neuropathology, Brain Res Rev 16 (1991), 283-300.
35. L. Li, X. An and J. Qiao, Pathological characteristics of Alzheimer's disease produced by lesion in nucleus basalis of Meynert in rats, Chin Med J 111 (1998), 638-640.
36. 2+-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease, Neurosci Lett 112 (1990), 338-342.
37. S.W. Looney and R.S. el-Mallakh, Meta-analysis of erythrocyte Na,K-ATPase activity in bipolar illness, Depress Anxiety 5 (1997), 53-65.
38. O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, Protein measurement with the Folin phenol reagent, J Biol Chem 193 (1951), 265-275.
39. H.J. Lüth, M. Holzer, U. Gärtner, M. Staufenbiel and T. Arendt, Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology, Brain Res 913 (2001), 57-67.
40. L. Mazzanti, E. Faloia, R.A. Rabini, R. Staffolani, A. Kantara, R. Fiorini, B. Swoboda, R. De Pirro and E. Bertoli, Diabetes mellitus induces red blood cell plasma membrane alterations possibly affecting the aging process, Clin Biochem 25 (1992), 41-46.
41. L. Mazzanti, R.A. Rabini, E. Salvolini, M. Tesei, D. Martarelli, B. Venerando and G. Curatola, Sialic acid, diabetes, and aging: A study on the erythrocyte membrane, Metabolism 46 (1997), 59-61.
42. M. Miyamoto, M. Shintani, A. Nagaoka and Y. Nagawa, Lesioning of the rat basal forebrain leads to memory impairments in passive and active avoidance tasks, Brain Res 328 (1985), 97-104.
43. B.B. Mršulja, N. Stojadinović, M. Maletić- Savatić, T. Stojanović, V. Cvejić, M. Jovičić , M. Nenadović, V.R. Paunović, D. Marinković and V.S. Kostić, Substrate kinetics pattern of erythrocyte membrane Na,K-ATPase: a potential ubiquitouse mechanism reflecting central nervouse system pathology, Iugosl Physiol Pharmacol Acta 29 (1993), 115-119.
44. I. Murdoch, J.A. Nicoll, D.I. Graham and D. Dewar, Nucleus basalis of Meynert pathology in the human brain after fatal head injury, J Neurotrauma 19 (2002), 279-284.
45. L. Nanetti, C. Moroni, A. Vignini, P. Vannini, C. Franceschi and L. Mazzanti, Age-related changes on platelet membrane: a study on elderly and centenarian monozygotic twins, Exp Gerontol 40 (2005), 519-525.
46. G.J. Naylor, D.A.T. Dick, E.P. Worrall, E.G. Dick, P. Dick and L. Boardman, Changes in the erythrocyte sodium pump with age, Gerontology 23 (1977), 256-261.
47. G. Paxinos and C. Watson, The rat brain in stereotaxic coordinates, Academic Press, Sydney, 1982.
48. N.D. Petronijević, D.V. Mićić, B. Djuričić, D. Marinković and V.R. Paunovic, Substrate kinetics of erythrocyte membrane Na,K-ATPase and lipid peroxides in schizophrenia, Prog Neuropsychopharmacol Biol Psychiatry 27 (2003), 431-440.
49. B. Platt, G. Fiddler, G. Riedel and Z. Henderson, Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence, Brain Res Bull 55 (2001), 257-267.
50. M. Popović, K. Jovanova-Nešić, N. Popović, D. Bokonjić, S. Dobrić, N. Rosić and Lj. Rakić, Behavioral and adaptive status in an experimental model of Alzheimer's disease in rats, Int J Neurosci 86 (1996), 281-299.
51. M. Popović, M. Caballero-Bleda, N. Popović, L. Puelles, T. Van Groen and M.P. Witter, Verapamil prevents, in dose-depedent way, the loss of ChAT-immunoreactive neurons in the cerebral cortex following lesions of the rat nucleus basalis magnocellularis, Exp Brain Res 170 (2006), 368-375.
52. S. Prabakaran, M. Wengenroth, H.E. Lockstone, K. Lilley, F.M. Leweke and S. Bahn, 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia, J Proteome Res 6 (2007), 141-149.
53. M.G. Repetto, C.G. Reides, P. Evelson, S. Kohan, E.S. de Lustig and S.F. Llesuy, Peripheral markers of oxidative stress in probable Alzheimer patients, Eur J Clin Invest 29 (1999), 643-649.
54. R. Rodrigo, J.P. Bächler, J. Araya, H. Prat and W. Passalacqua, Relationship between (Na + K)-ATPase activity, lipid peroxidation and fatty acid profile in erythrocytes of hypertensive and normotensive subjects, Mol Chem Biochem 303 (2007), 73-81.
55. + as individual characteristics, Life Sci 29 (1981), 371-381.
56. +) ATPase, Toxicology 236 (2007), 158-177.
57. +, ATPase activity: Technical factors, feeding, aging, Am J Clin Nutr 40 (1984), 339-345.
58. A. Skoumalova, J. Rofina, Z. Schwippelova, E. Gruys and J. Wilhelm, The role of free radicals in canine counterpart of senile dementia of the Alzheimer type, Exp Gerontol 38 (2003), 711-719.
59. J.D. Stoehr, S.L. Mobley, D. Roice, R. Brooks, L.M. Baker, R.G. Wiley and G.L. Wenk, The effects of selective cholinergic basal forebrain lesions and aging upon expectancy in the rat, Neurobiol Learn Mem 67 (1997), 214-227.
60. T. Stojanović and B.B. Mršulja, Alterations in synaptosomal membrane Na,K-ATPase of the gerbil cortex and hippocampus following reversible brain ischemia, Metab Brain Dis 3 (1988), 265-272.
61. A.Y. Sun, Y. Cheng, Q. Bu and F. Oldfield, The biochemical mechanisms of the excitotoxicity of kainic acid. Free radical formation, Mol Chem Neuropathol 17 (1992), 51-63.
62. +-ATPase activity in rat brain, J Neurochem 49 (1987), 83-87.
63. H.H. Taussky and E. Shorr, A microcolorimetric method for the determination of inorganic phosphorus, J Biol Chem 202 (1953), 675-685.
64. A. Toledano and M.I. Alvarez, Lesions and dysfunctions of the nucleus basalis as Alzheimer's disease models: general and critical overview and analysis of the long-term changes in several excitotoxic models, Curr Alzheimer Res 1 (2004), 189-214.
65. C. Van den Heuvel, E. Thornton and R. Vink. Traumatic brain injury and Alzheimer's disease: a review, Prog Brain Res 161 (2007), 303-316.
66. A. Vignini, L. Nanetti, C. Moroni, L. Tanase, M. Bartolini, S. Luzzi, L. Provinciali and L. Mazzanti, Modifications of platelet from Alzheimer disease patients: A possible relation between membrane properties and NO metabolites, Neurobiol Aging 28 (2007), 987-994.
67. R.A. Yokel, The toxicology of aluminum in the brain: a review, Neurotoxicology 21 (2000), 813-828.
68. J.R. Walton, An aluminium-based rat model of Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration, J Inorg Biochem 101 (2007), 1275-1284.
69. A. Zanella, C. Izzo, G. Meola, M. Mariani, M.T. Colotti, V. Silani, G. Pellegata and G. Scarlato, Metabolic impairment and membrane abnormality in red cells from Huntington's disease, J Neurol Sci 47 (1980), 93-103.